A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults
A Phase 2, Partially-Blinded, Randomized, Comparative Study of the Efficacy of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole for the Treatment of Trichuris Trichiura Infection in Adults
Sponsor: Asociacion Benefica Prisma
A PHASE2 clinical study on Trichuriasis, this trial is actively recruiting participants. The trial is conducted by Asociacion Benefica Prisma and has accumulated 12 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE2
-
May 2025 — Aug 2025 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — May 2025 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
▶ Show 7 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2021 — Oct 2023 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE2
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Asociacion Benefica Prisma
- National Institutes of Health (NIH)
- Policlinico Asociacion Benefica PRISMA-Laboratorio Satelite IQTLAB
- University of Iowa
- University of Virginia
For direct contact, visit the study record on ClinicalTrials.gov .